HansBiomed Corporation (KOSDAQ:042520)

HansBiomed Ratios and Metrics

Market cap in millions KRW. Fiscal year is October - September.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 5, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Market Capitalization	548,079	235,973	127,792	207,570	92,964	160,691
Market Cap Growth	364.27%	84.65%	-38.43%	123.28%	-42.15%	-29.01%
Enterprise Value	583,420	268,360	153,787	241,607	132,643	187,080
Last Close Price	40000.00	18170.00	9840.00	17930.00	9610.00	16050.00
PE Ratio	-	-	-	-	15.12	-
Forward PE	39.60	6.95	6.95	6.95	6.95	6.95
PS Ratio	6.10	2.63	1.58	2.66	1.25	2.72
PB Ratio	16.17	6.96	1.90	4.16	1.96	3.38
P/TBV Ratio	16.52	7.11	1.93	4.29	2.08	3.70
P/OCF Ratio	1721.69	741.27	72.67	-	-	-
EV/Sales Ratio	6.50	2.99	1.90	3.10	1.78	3.17
EV/EBITDA Ratio	-	-	25.58	231.57	21.54	-
EV/EBIT Ratio	-	-	245.82	-	105.60	-
EV/FCF Ratio	-377.89	-	-	-	-	-
Debt / Equity Ratio	1.28	1.28	0.54	0.82	1.18	1.08
Debt / EBITDA Ratio	-	-	6.06	39.43	9.08	-
Asset Turnover	0.72	0.72	0.67	0.61	0.57	0.45
Inventory Turnover	1.34	1.34	1.05	1.20	1.26	1.64
Quick Ratio	0.31	0.31	0.38	0.31	0.32	0.49
Current Ratio	0.69	0.69	0.99	0.77	0.73	0.84
Return on Equity (ROE)	-63.51%	-63.51%	-13.33%	-49.47%	10.36%	-37.86%
Return on Assets (ROA)	-14.05%	-14.05%	0.32%	-2.04%	0.60%	-9.46%
Return on Invested Capital (ROIC)	-34.05%	-33.74%	0.69%	-4.78%	1.49%	-25.01%
Return on Capital Employed (ROCE)	-61.50%	-61.50%	0.90%	-7.30%	2.20%	-28.90%
Earnings Yield	-5.72%	-13.28%	-5.65%	-11.10%	6.61%	-11.38%
FCF Yield	-0.28%	-0.65%	-0.65%	-2.73%	-8.88%	-12.16%
Buyback Yield / Dilution	-0.29%	-0.29%	-20.83%	18.41%	-31.21%	-1.48%
Total Shareholder Return	-0.29%	-0.29%	-20.83%	18.41%	-31.21%	-1.48%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.